Company

Legend Biotech

Public · Nasdaq: LEGNbiotechnologyUnited States

Legend Biotech develops and manufactures novel cell therapies, particularly CAR-T treatments for cancer.

Legend Biotech is a publicly traded company operating in the biotechnology sector, based in the United States. It trades on the Nasdaq under the ticker LEGN. Leadership tracked by CEOInsider includes Ingrid Zhang (CEO).

www.legendbiotech.com ↗LinkedIn ↗

Leadership

Current

Ingrid Zhang

CEO

Recent developments

AI summary of recent coverage

Recent coverage has focused on Legend Biotech's appointment of Ingrid Zhang as Chief Executive Officer, with Zhang bringing prior executive experience from Novartis to the role. The leadership transition has been characterized as marking a new chapter for the cell therapy company as it enters its next growth phase.

Summarized from the headlines in the sidebar; see each source for the full story.